Application of Linked Color Imaging(LCI) in Diagnosis of Early Gastric Cancer(EGC)

NCT03661671 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2400

Last updated 2018-09-07

No results posted yet for this study

Summary

the purpose of this study is to evaluate application value of LCI in the diagnosis of early gastric cancer.

Conditions

  • Early Gastric Cancer

Interventions

DIAGNOSTIC_TEST

LCI+white light

Firstly use white light to observe from cardia to duodenum and then switch LCI model to observe from antrum to cardia

Sponsors & Collaborators

  • Shanxi Province Cancer Hospital

    collaborator OTHER
  • First People's Hospital of Hangzhou

    collaborator OTHER
  • 307 Hospital of PLA

    collaborator OTHER
  • Jiangsu Province Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • The First Affiliated Hospital of Anhui Medical University

    collaborator OTHER
  • The First Affiliated Hospital of Nanchang University

    collaborator OTHER
  • Zhongshan Hospital Xiamen University

    collaborator OTHER
  • Chongqing University Cancer Hospital

    collaborator OTHER
  • Guilin Medical University, China

    collaborator OTHER
  • Guangdong Provincial Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Xiangya Hospital of Central South University

    collaborator OTHER
  • Wuhan University

    collaborator OTHER
  • Xi'an Central Hospital

    collaborator OTHER
  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Zhaoshen Li, M.D · Department of Gastroenterology, Changhai Hospital, Second Military Medical University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-01-01
Completion
2019-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03661671 on ClinicalTrials.gov